Rivaroxaban, Treatment of DVT or PE

Warning

exp date isn't null, but text field is

Abstract

Rivaroxaban is an oral anticoagulant that has been approved for the treatment and prevention of recurrence of deep vein thrombosis (DVT) and/or pulmonary embolism (PE). Apixaban remains the anticoagulant of choice in this patient group in NHSGGC. However occasionally rivaroxaban may be the preferred option due to previous intolerance to apixaban (thought unlikely to be related to drug class), or recognised benefit of once daily dosing.

Resources

Use the button below to access this resource item.

Access this resource

Tags

Acute / All Inpatient

Last reviewed: 12 July 2018

Next review: 13 August 2021

Author(s): Catherine Bagot

Version: 5

Author Email(s): catherine.bagot.scot.nhs.uk

Approved By: Medicines Utilisation Subcommittee of ADTC

Document Id: 144